GeneReach Biotechnology Corp.

TPEX:4171 Stock Report

Market Cap: NT$1.9b

GeneReach Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Compra con información privilegiada: Datos insuficientes para determinar si personas con información privilegiada han comprado más acciones de las que han vendido en los últimos 3 meses.


Ownership Breakdown

What is the ownership structure of 4171?
Owner TypeNumber of SharesOwnership Percentage
Institutions313.5780,546 %
General Public57.143.92299,5 %

Dilución de acciones: Los accionistas no se han visto significativamente diluidos en el último año.


Top Shareholders

Top 3 shareholders own 0.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
0,51 %
Dimensional Fund Advisors LP
295.171NT$9.7m-0,11 %no data
0,032 %
American Century Investment Management Inc
18.157NT$596.4k0 %no data
0,00044 %
Norges Bank Investment Management
250NT$8.3k-100 %no data
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.